Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Glutamate, Hyperarousal and Restless Legs Syndrome

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Richard Allen, Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT01675323
First received: August 27, 2012
Last updated: October 13, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2016
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)